Clinical, Neurophysiological and Radiological Evaluation of Patients With Basal Ganglia Lesions

Basal Ganglia Lesions Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00169325
• Other study ID #: P031201
• Status: Completed
• Phase: N/A
• First received: September 12, 2005
• Last updated: September 11, 2015
• Start date: September 2005
• Est. completion date: January 2014

Study information

• Verified date: September 2015
• Source: Groupe Hospitalier Pitie-Salpetriere
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Basal ganglia are involved in the control of motor, cognitive and emotional behaviours. The aim of this study is to precisely evaluate patients with basal ganglia focal lesions both with or without loss of psychic-self activation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 11
• Est. completion date: January 2014
• Est. primary completion date: January 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Basal ganglia lesions

Exclusion Criteria:

• Contraindication to magnetic resonance imaging (MRI)

• Dementia

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Basal Ganglia Lesions
• Ganglion Cysts

Intervention

Procedure:
• Magnetic resonance imaging

Locations

Country	Name	City	State
France	Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Marie-laure Welter

Country where clinical trial is conducted

France,